[1]刘宁,徐展望,王明喜,等.蠲痹汤“异病同治”法治疗类风湿关节炎和强直性脊柱炎的网络药理学作用机制研究[J].西部中医药,2023,36(10):20-26.[doi:10.12174/j.issn.2096-9600.2023.10.04]
　LIU Ning,XU Zhanwang,WANG Mingxi,et al.Network Pharmacology-based Study on the Mechanism of Treating Rheumatoid Arthritis and Ankylosing Spondylitis with Juanbi Decoction Based on "Treating Different Diseases with Same Method"[J].Western Journal of Traditional Chinese Medicine,2023,36(10):20-26.[doi:10.12174/j.issn.2096-9600.2023.10.04]
点击复制

蠲痹汤“异病同治”法治疗类风湿关节炎和强直性脊柱炎的网络药理学作用机制研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年10期
页码:
20-26
栏目:
出版日期:
2023-10-15

文章信息/Info

Title:
Network Pharmacology-based Study on the Mechanism of Treating Rheumatoid Arthritis and Ankylosing Spondylitis with Juanbi Decoction Based on "Treating Different Diseases with Same Method"
作者:
刘宁1, 徐展望2, 王明喜2, 谭国庆2
1.山东中医药大学，山东 济南 250035
2.山东中医药大学附属医院，山东 济南 250035
Author(s):
LIU Ning1, XU Zhanwang2, WANG Mingxi2, TAN Guoqing2
1.Shandong University of Traditional Chinese Medicine, Jinan 250035, China
2.Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250035, China
关键词:
类风湿关节炎; 强直性脊柱炎; 蠲痹汤; 异病同治; 网络药理学
Keywords:
rheumatoid arthritis; ankylosing spondylitis; decoction; treating different diseases with same method; network pharmacology
分类号:
R593.22
DOI:
10.12174/j.issn.2096-9600.2023.10.04
文献标志码:
A
摘要:
目的通过网络药理学原理探讨蠲痹汤“异病同治”法治疗类风湿关节炎和强直性脊柱炎的潜在作用机制。 方法在中药系统药理学数据库平台检索蠲痹汤的活性成分并预测其潜在靶点，借助Cytoscape 3.7.2软件构建药物成分与靶点之间的网络图；通过疾病相关数据库平台检索类风湿关节炎和强直性脊柱炎的疾病靶点，利用Venny在线工具构建药物与疾病的关键靶点Venny图。基于STRING数据库构建蛋白间PPI网络图，然后按Dgree值大于平均值进一步筛选核心靶点；运用DAVID数据库，对基因本体及基因组百科全书通路富集进行分析。 结果经过筛选得到蠲痹汤有效活性成分153个，潜在作用靶点137个，经疾病数据库获得强直性脊柱炎靶点188个，类风湿关节炎靶点729个，映射靶点23个，根据Dgree≥11筛选到10个核心靶点作用于一氧化氮生物合成过程的正调控、细胞因子活性、细胞对脂多糖的反应等119项生物过程及TNF信号通路、NOD样受体通路、Toll样受体通路、HIF-1信号通路等32条相关生物通路，进而调节体内炎症反应及氧化应激水平。 结论依据网络药理学相关技术方法能够较为科学的从分子水平层面揭示蠲痹汤“异病同治”类风湿关节炎和强直性脊柱炎的潜在作用机制，为进一步的临床应用和实验验证提供理论基础与依据。
Abstract:
ObjectiveTo explore the potential mechanism of treating rheumatoid arthritis and ankylosing spondylitis with Juanbi decoction on the foundation of "treating different diseases with same method" through the principle of network pharmacology. MethodsThe active ingredients of Juanbi decoction were searched from Traditional Chinese Medicine System Pharmacology Database Platform (TCMSP) to predict the potential targets, a network diagram between the ingredients of the drugs and the targets was constructed via Cytoscape 3.7.2 software; the targets of rheumatoid arthritis and ankylosing spondylitis were retrieved by disease-related database platform, Venny diagram of key targets of drugs and diseases was constructed utilizing Venny online tools. PPI network diagram between proteins was built based on the STRING database, and then the core targets were further screened according to the Dgree value greater than the average value; gene ontology (GO) and genome encyclopedia (KEGG) were analyzed using DAVID database. ResultsThrough screening, there are 153 active ingredients and 137 potential action targets from Juanbi decoction, 188 targets related to ankylosing spondylitis, 729 targets of rheumatoid arthritis and 23 mapping targets were obtained via disease database, ten core targets were screened according to Dgree≥11, acting on 119 biological processes including positive regulation of nitric oxide biosynthesis, the activity of cytokine, cell response to lipopolysaccharide, and 32 associated biological pathways containing TNF signal pathway, NOD-like receptor pathway, Toll-like receptor pathway and HIF-1 signal pathway, thereby regulating human inflammatory response and oxidative stress levels in vivo. ConclusionThe potential mechanism of Juanbi decoction in the treatment of rheumatoid arthritis and ankylosing spondylitis on the foundation of "treating different diseases with same method" is revealed in a scientific way from molecular level through the related technology and methods of network pharmacology, which could produce theoretical foundation and reference for further clinical application and experimental verification.

相似文献/References:

[1]马建辉,雷学峰,吕健△.中西医药物配合手法治疗类风湿性关节炎60例临床观察[J].西部中医药,2013,26(01):97.
　MA Jianhui,LEI Xuefeng,LV Jian.Integrative Medicine and Manipulation in the Treatment for 60 Cases of Rheumatoid Arthritis[J].Western Journal of Traditional Chinese Medicine,2013,26(10):97.
[2]易竞阳.补肾强督祛风通络法治疗强直性脊柱炎临床疗效观察[J].西部中医药,2013,26(11):5.
　YI Jingyang.Clinical Observation on Treating Ankylosing Spondylitis with the Method of Kidney-nourishing Du-meridian-strengthening Wind-dispelling Collaterals-dredging[J].Western Journal of Traditional Chinese Medicine,2013,26(10):5.
[3]张晓琴,何东初.复方玄驹胶囊联合甲氨蝶呤、来氟米特治疗类风湿关节炎40例[J].西部中医药,2012,25(05):78.
　ZHANG Xiao-qin,HE Dong-chu.Treatment of Rheumatoid Arthritis with Compound XuanJu Capsule combined with Methotrexate and Leflunomide: A Report of 40 Cases[J].Western Journal of Traditional Chinese Medicine,2012,25(10):78.
[4]刘安国,严兴科△,阚丽丽,等.铺灸疗法为主治疗强直性脊柱炎的Meta分析*[J].西部中医药,2013,26(12):51.
　LIU Anguo,YAN Xingke,KAN Lili,et al.Meta Analysis of Primary Treatment for Ankylosing Spondylitis by Long Snake Moxibustion[J].Western Journal of Traditional Chinese Medicine,2013,26(10):51.
[5]刘渊,孙雪莲,周红海△.整脊经筋手法治疗强直性脊柱炎早中期患者临床研究*[J].西部中医药,2014,27(05):111.
　LIU Yuan,SUN Xuelian,ZHOU Honghai.Clinical Study on Treating the Patients with Ankylosing Spondylitis at Early and Medium Stages by Chiropractic and Meridian Manipulations[J].Western Journal of Traditional Chinese Medicine,2014,27(10):111.
[6]王爱华,指导：王海东.小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变30例[J].西部中医药,2015,28(04):120.
[7]王佳,王钢,王丽琴,等.秦艽醇提物治疗类风湿关节炎的实验研究[J].西部中医药,2015,28(07):11.
[8]鄢卫平,李景周,强天明.针刀治疗强直性脊椎炎60例[J].西部中医药,2013,26(12):118.
　YAN Weiping,LI Jingzhou,QIANG Tianming.Treating 60 Cases of Ankylosing Spondylitis by Needle-knife[J].Western Journal of Traditional Chinese Medicine,2013,26(10):118.
[9]刘佳,盛丽,张宝洲,等.类风湿性关节炎膝关节病变的高频超声评价[J].西部中医药,2015,28(10):134.
[10]陈慕芝,孙红艳,照日格图△.223例类风湿关节炎患者中医证候及实验室指标分析[J].西部中医药,2016,29(05):67.
　CHEN Muzhi,SUN Hongyan,ZHAORI Getu.The Analysis of Lab Indicators and TCM Patterns of 223 Patients with Rheumatoid Arthritis[J].Western Journal of Traditional Chinese Medicine,2016,29(10):67.

备注/Memo

备注/Memo:
刘宁（1995—），男，硕士学位，医师。研究方向：脊柱脊髓损伤、脊柱退行性疾病及骨质疏松症的基础与临床研究。国家自然科学基金（81473709）；曹贻训全国名老中医传承工作室建设项目（国中医药人教函［2018］134号）；徐展望山东省名老中医药专家传承工作室建设项目（山东省卫生健康委员会，鲁卫函［2019］92号）；王明喜山东省名老中医药专家传承工作室（鲁财社指［2018］20号）。
更新日期/Last Update: 1900-01-01